U.S. Markets close in 4 hrs 17 mins
  • S&P 500

    4,355.42
    -77.57 (-1.75%)
     
  • Dow 30

    34,029.26
    -555.62 (-1.61%)
     
  • Nasdaq

    14,707.50
    -336.47 (-2.24%)
     
  • Russell 2000

    2,181.76
    -55.11 (-2.46%)
     
  • Crude Oil

    70.98
    -0.99 (-1.38%)
     
  • Gold

    1,764.20
    +12.80 (+0.73%)
     
  • Silver

    22.36
    +0.07 (+0.29%)
     
  • EUR/USD

    1.1734
    +0.0003 (+0.0235%)
     
  • 10-Yr Bond

    1.3260
    -0.0440 (-3.21%)
     
  • Vix

    25.02
    +4.21 (+20.23%)
     
  • GBP/USD

    1.3666
    -0.0071 (-0.5166%)
     
  • USD/JPY

    109.4780
    -0.4170 (-0.3795%)
     
  • BTC-USD

    44,590.88
    -3,435.44 (-7.15%)
     
  • CMC Crypto 200

    1,094.95
    -39.43 (-3.48%)
     
  • FTSE 100

    6,902.37
    -61.27 (-0.88%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ACAD, WISH and SPCE

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / June 14, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

Investors Affected: June 15, 2020 - April 4, 2021

A class action has commenced on behalf of certain shareholders in Acadia Pharmaceuticals Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin supplemental new drug application (sDNA) contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the Food and Drug Administration Agency was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/acadia-pharmaceuticals-inc-loss-submission-form/?id=16849&from=1

Contextlogic Inc. (NASDAQ:WISH)

This lawsuit is on behalf of investors who purchased WISH pursuant or traceable to the registration statement and prospectus issued in connection with ContextLogic's December 16, 2020 initial public stock offering or between December 16, 2020 and May 12, 2021.

A class action has commenced on behalf of certain shareholders in Contextlogic Inc. In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic's business operations and financial prospects by overstating its then-present monthly active users ("MAUs") and MAU growth trends.

Shareholders may find more information at https://securitiesclasslaw.com/securities/contextlogic-inc-loss-submission-form/?id=16849&from=1

Virgin Galactic Holdings, Inc. (NYSE:SPCE)

Investors Affected: October 26, 2019 - April 30, 2021

A class action has commenced on behalf of certain shareholders in Virgin Galactic Holdings, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) for accounting purposes, Social Capital Hedosophia Holdings Corp.'s ("SCH") warrants were required to be treated as liabilities rather than equities; (ii) Virgin Galactic had deficient disclosure controls and procedures and internal control over financial reporting; (iii) as a result, the Company improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/virgin-galactic-holdings-inc-loss-submission-form/?id=16849&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/651626/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-ACAD-WISH-and-SPCE